Leukotriene Pathway Activation Associates with Poor Glycemic Control and with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes

<div>Expressions of ALOX5, MYD88, LTB4R, DDOST, SIRT1, and AGER mRNAs (a–f, respectively) in nondiabetic controls and in type 1 diabetes individuals sorted into Groups A and B (adjusted for sex, age, and use of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and statin).</div>

Mediators of Inflammation

fig4

Figure 4

Figure 4: Leukotriene Pathway Activation Associates with Poor Glycemic Control and with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes 